Anda di halaman 1dari 7

.

LPL - PSC-MUKHERJEE NGR.


A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

Mr. SAUJANYA SENGAR

Lab No.

111305573

Age: 22 Years

A/c Status

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:02PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

0.75

ng/mL

0.60 - 1.81

THYROID PROFILE TOTAL(CGHS)


T3, TOTAL, SERUM
(CLIA)

Note: Total T3 & T4 levels measure the hormone which is in the bound form and is not available to most

tissues. In addition severe systemic illness which affects the thyroid binding proteins can falsely alter Total
T4 levels in the absence of a primary thyroid disease. Hence Free T 3 & T4 levels are recommended for
accurate assessment of thyroid dysfunction.
Clinical Use

Diagnose and monitor treatment of Hyperthyroidism

Increased Levels: Pregnancy, Graves disease, T3 thyrotoxicosis, TSH dependent Hyperthyroidism,

Increased TBG
Decreased Levels: Nonthyroidal illness, Hypothyroidism , Nutritional deficiency, Systemic illness,

Decreased TBG
6.60

T4, TOTAL, SERUM


(CLIA)

ug/dL

5.01 - 12.45

Note

1. Total T3 & T4 levels measure the hormone which is in the bound form and is not available to most
tissues.
2. Severe systemic illness affects the thyroid binding proteins and can falsely alter Total T 4 levels in the
absence of a primary thyroid disease. Hence Free T3 & T4 levels are recommended for accurate
assessment of thyroid dysfunction
Clinical Use

Diagnose Hypothyroidism and Hyperthyroidism when overt and / or due to pituitary or hypothalamic
disease.

Increased Levels: Hyperthyroidism, Increased TBG, Familial dysalbuminemic hyperthyroxinemia,

Increased Transthyretin, Estrogen therapy, Pregnancy


Decreased Levels: Primary hypothyroidism, Pituitary TSH deficiency, Hypothalamic TRH deficiency, Non

thyroidal illness, Decreased TBG.


TSH, SERUM
(CLIA)

1.88

uIU/mL

0.35 - 5.50

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 1 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

Mr. SAUJANYA SENGAR

Lab No.

111305573

Age: 22 Years

A/c Status

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Results

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:02PM

Report Status

: Final

Units

Bio. Ref. Interval

Note

1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50%, hence time of the day has influence
on the measured serum TSH concentrations.
Clinical Use

Diagnose Hypothyroidism and Hyperthyroidism

Monitor T4 replacement or T4 suppressive therapy

Quantify TSH levels in the subnormal range

Increased Levels: Primary hypothyroidism, Subclinical hypothyroidism, TSH dependent

Hyperthyroidism, Thyroid hormone resistance


Decreased Levels: Graves disease, Autonomous thyroid hormone secretion, TSH deficiency

GLUCOSE, RANDOM (R), PLASMA


(Hexokinase)

79.00

mg/dL

70.00 - 140.00

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 2 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

: Mr. SAUJANYA SENGAR

Lab No.

: 111305573

Age: 22 Years

A/c Status

: P

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:06PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

Cholesterol Total

162.00

mg/dL

<200.00

Triglycerides

146.00

mg/dL

<150.00

HDL Cholesterol

41.00

mg/dL

40.00 - 60.00

LDL Cholesterol

91.80

mg/dL

<100.00

VLDL Cholesterol

29.20

mg/dL

<30.00

Non-HDL Cholesterol

121.00

mg/dL

LIPID PROFILE, BASIC, SERUM


(Spectrophotometry, Calculated)

Interpretation
-------------------------------------------------------------------------| NCEP RECOMMENDATIONS| TOTAL CHOLESTEROL | TRIGLYCERIDE |LDL CHOLESTEROL |
|
| in mg/dL
| in mg/dL
|in mg/dL
|
|---------------------|-------------------|--------------|-----------------|
| Optimal
| <200
| <150
| <100
|
|---------------------|-------------------|--------------|-----------------|
| Above Optimal
| | | 100-129
|
|---------------------|-------------------|--------------|-----------------|
| Borderline High
| 200-239
| 150-199
| 130-159
|
|---------------------|-------------------|--------------|-----------------|
| High
| >=240
| 200-499
| 160-189
|
|---------------------|-------------------|--------------|-----------------|
| Very High
| | >=500
| >=190
|
--------------------------------------------------------------------------

Note

1. Measurements in the same patient can show physiological & analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. As per NCEP guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. NCEP identifies elevated Triglycerides as an independent risk factor for Coronary Heart Disease (CHD).
4. Low HDL levels are associated with Coronary Heart Disease due to insufficient HDL being available to
participate in reverse cholesterol transport, the process by which cholesterol is eliminated from
peripheral tissues.
5. ATP III guidelines uses LDL Cholesterol as the primary target for cholesterol lowering therapy. Note that
major risk factors can modify LDL goals.
NON HDL CHOLESTEROL
----------------------------------------------------------------------| RISK CATEGORY
| LDL GOAL (mg/dL)
| NON HDL GOAL (mg/dL) |
|----------------------|-------------------------|----------------------|
| CHD & CHD risk
| < 100
| < 130
|
| equivalent (10 year |
|
|
| risk for CHD > 20 %) |
|
|
----------------------------------------------------------------------PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 3 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

: Mr. SAUJANYA SENGAR

Lab No.

: 111305573

Age: 22 Years

A/c Status

: P

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Results

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:06PM

Report Status

: Final

Units

Bio. Ref. Interval

----------------------------------------------------------------------| Multiple (2+) Risk


| < 130
| < 160
|
| Factors and 10 year |
|
|
| risk < or = 20%
|
|
|
|----------------------|-------------------------|----------------------|
| 0-1 Risk factor
| < 160
| <190
|
-----------------------------------------------------------------------

Comments

ATP III suggested the addition of Non HDL Cholesterol (Total Cholesterol - HDL Cholesterol) as an indicator of
all atherogenic lipoproteins (mainly LDL & VLDL). The Non HDL Cholesterol is used as a secondary target of
therapy in persons with triglycerides >=200 mg/dL. The goal for Non HDL Cholesterol in those with increased
triglyceride is 30 mg/dL above that set for LDL Cholesterol.
For calculation of CHD risk, history of smoking, any medication for hypertension & current blood pressure
levels are required.
LIVER PANEL 1; LFT,SERUM
(Spectrophotometry)

AST (SGOT)

27

U/L

<50

ALT (SGPT)

35

U/L

<50

GGTP

27

U/L

<55

Alkaline Phosphatase (ALP)

97

U/L

30 - 120

Bilirubin Total

0.81

mg/dL

0.30 - 1.20

Bilirubin Direct

0.15

mg/dL

<0.20

Bilirubin Indirect

0.66

mg/dL

<1.10

Total Protein

6.90

g/dL

6.40 - 8.30

Albumin

4.11

g/dL

3.50 - 5.20

A : G Ratio

1.47

0.90 - 2.00

KIDNEY PANEL; KFT,SERUM


(Spectrophotometry, Indirect ISE)

Urea

14.00

mg/dL

17.00 - 43.00

Creatinine

1.02

mg/dL

0.67 - 1.17

Uric Acid

6.80

mg/dL

3.50 - 7.20

Alkaline Phosphatase (ALP)

97

U/L

30 - 120

Total Protein

6.90

g/dL

6.40 - 8.30

Albumin

4.11

g/dL

3.50 - 5.20

A : G Ratio

1.47

0.90 - 2.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 4 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

: Mr. SAUJANYA SENGAR

Lab No.

: 111305573

Age: 22 Years

A/c Status

: P

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:06PM

Report Status

: Final

Test Name

Results

Units

Bio. Ref. Interval

Calcium, Total

9.20

mg/dL

8.80 - 10.60

Phosphorus

2.60

mg/dL

2.40 - 4.40

Sodium

135.00

mEq/L

136.00 - 146.00

Potassium

4.27

mEq/L

3.50 - 5.10

Chloride

100.00

mEq/L

101.00 - 109.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 5 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

: Mr. SAUJANYA SENGAR

Lab No.

111305573

Age: 22 Years

A/c Status

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:09PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

Hemoglobin

15.60

g/dL

13.00 - 17.00

Packed Cell Volume (PCV)

48.80

40.00 - 50.00

RBC Count

5.66

mill/mm3

4.50 - 5.50

MCV

86.30

fL

80.00 - 100.00

MCH

27.50

pg

27.00 - 32.00

MCHC

31.90

g/dL

32.00 - 35.00

Red Cell Distribution Width (RDW)

13.10

11.50 - 14.50

Total Leukocyte Count (TLC)

8.90

thou/mm3

4.00 - 10.00

Segmented Neutrophils

64.40

40.00 - 80.00

Lymphocytes

25.30

20.00 - 40.00

Monocytes

7.10

2.00 - 10.00

Eosinophils

3.00

1.00 - 6.00

Basophils

0.20

<2.00

Neutrophils

5.73

thou/mm3

2.00 - 7.00

Lymphocytes

2.25

thou/mm3

1.00 - 3.00

Monocytes

0.63

thou/mm3

0.20 - 1.00

Eosinophils

0.27

thou/mm3

0.02 - 0.50

Basophils

0.02

thou/mm3

0.01 - 0.10

Platelet Count

185.0

thou/mm3

150.00 - 450.00

ESR

17

mm/hr

0 - 15

HEMOGRAM
(Electrical Impendance & VCS, Capillary photometry)

Differential Leucocyte Count (DLC)

Absolute Leucocyte Count

Note

1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

PatientReportSCSuperPanel.CBC_SC (Version: 4)

Page 6 of 7

.
LPL - PSC-MUKHERJEE NGR.
A - 37,38,39, GROUND FLOOR,
GF - 2, COMM ERCIAL
COMPLEX, DR. MUKHERJEE
NAGAR, ADJ

Name

: Mr. SAUJANYA SENGAR

Lab No.

111305573

Age: 22 Years

A/c Status

Ref By :

Gender:

Male

CGHS DISPENSARY [CASH]

Test Name

Collected
Received
Reported

: 13/3/2015 8:00:00AM
: 13/3/2015 8:02:08AM
: 13/3/2015 12:37:09PM

Report Status

: Final

Results

Dr. Nimmi Kansal


MD (Biochemistry)
HOD Biochem & IA

Units

Bio. Ref. Interval

Dr. Sushrut Pownikar


DNB (Pathology)
HOD Hemat & Imm

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.CBC_SC (Version: 4)

Page 7 of 7